The Scientist1y
Driving Changes in Ligand Theory
AGONIZING DIFFERENCES:© 2004 Macmillan Magazines Ltd.(A) GPCR agonists increase the proportion of active receptor states; inverse agonists decrease the proportion of active receptor states; and ...
American Association of Individual Investors8d
Why Alto Neuroscience, Inc.’s (ANRO) Stock Is Down 10.13%
Alto Neuroscience, Inc.’s ANRO share price has dipped by 10.13%, which has investors questioning if this is right time to buy ...
pharmaphorum4d
Novo Nordisk’s oral amycretin tops Wegovy in obesity trial
Data on the subcutaneous version of amycretin is due next year, and Novo Nordisk also presented early data on another oral therapy, CBR1 inverse agonist monlunabant (INV-202), which showed a 3% ...
Nature4y
The peripheral CB1 blockade: a novel therapeutic avenue to address key metabolic conditions
Inversago Pharma, based in Montreal, Canada, is working on safer generations of peripherally-acting cannabinoid receptor-1 (CB1) inverse agonists, based on research carried out by George Kunos ...